DRUGRECURE ApS: Financial statements 2023
CVR: 29154406
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
DRUGRECURE ApS (CVR 29154406) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -99,396,000 and a net result of DKK -133,501,000 compared with DKK -84,355,000 the year before. Equity in the 2023 report amounted to DKK -803,088,000.
- Gross Profit
- DKK -99,396,000
- Profit/Loss
- DKK -133,501,000
- Equity
- DKK -803,088,000
- Total Assets
- DKK 46,994,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -99.4M | -133.5M | -803.1M | - |
| 2022 | - | -66.1M | -84.4M | -669.6M | - |
| 2021 | - | -88.6M | -140.2M | -292M | - |
| 2020 | - | -121.7M | -143M | -151.8M | - |
| 2019 | - | -33.8M | -60.1M | -8.8M | 0 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
DRUGRECURE ApS has published its annual report for 2022. Gross profit came to DKK -66,145,000, and the net result was DKK -84,355,000.
About DRUGRECURE ApS
DRUGRECURE ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2005. The company is registered under the industry Traditionelle, komplementære og alternative behandlingsformer. The company was previously named ApS KBUS 17 NR. 4495. The management consists of Danielle Marie Brown. The company is owned by Savara ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -231,083,000 and a net result of DKK -282,428,000 compared with DKK -274,629,000 the year before. Equity in the 2025 report amounted to DKK -1,360,145,000.